Skip to main content
. 2022 Oct 10;10:1012142. doi: 10.3389/fpubh.2022.1012142

Table 2.

Univariate and multivariate Cox proportional hazards regression analyses for overall survival.

Variable Univariate Multivariate adjusted*
HR (95% CI) p-value HR (95% CI) p-value
Treatment type
Non-RT and non-surgery Ref Ref
RT 0.68 (0.58–0.79) <0.001 0.77 (0.66–0.89) <0.001
Surgery 0.31 (0.30–0.33) <0.001 0.52 (0.48–0.56) <0.001
RT and surgery 0.27 (0.25–0.29) <0.001 0.42 (0.38–0.46) <0.001
Age
<70 Ref Ref
≥70 1.33 (1.27–1.40) <0.001 1.42 (1.35–1.49) <0.001
Sex
Female Ref Ref
Male 1.04 (0.99–1.10) 0.126 1.10 (1.04–1.16) <0.001
Year of diagnosis
2004–2009 Ref Ref
2010–2015 0.96 (0.91–1.00) 0.069 0.95 (0.90–1.00) 0.047
Marital status
Married Ref Ref
Others 1.16 (1.10–1.21) <0.001 1.18 (1.12–1.24) <0.001
Race
White Ref Ref
Others 1.01 (0.95–1.07) 0.782 1.02 (0.96–1.08) 0.517
Stage
Localized Ref Ref
Regional 2.34 (2.18–2.50) <0.001 2.41 (2.24–2.59) <0.001
Distant 4.13 (3.88–4.39) <0.001 3.66 (3.40–3.94) <0.001
Grade
I Ref Ref
II 1.52 (1.39–1.67) <0.001 1.36 (1.24–1.49) <0.001
III 2.43 (2.22–2.67) <0.001 1.85 (1.68–2.03) <0.001
IV 2.51 (2.09–3.00) <0.001 1.94 (1.61–2.33) <0.001
Unknown 3.13 (2.85–3.44) <0.001 1.43 (1.29–1.58) <0.001
Tumor size
<5 cm Ref Ref
≥5 cm 1.76 (1.64–1.89) <0.001 1.29 (1.20–1.39) <0.001
Unknown 1.82 (1.72–1.92) <0.001 1.36 (1.29–1.44) <0.001
Chemotherapy
No/Unknown Ref Ref
Yes 1.17 (1.11–1.22) <0.001 0.69 (0.65–0.74) <0.001

HR, hazard ratio; CI, confidence interval; RT, radiotherapy; Ref, reference.

The hazard ratio (HR) and 95% confidence interval (CI) were calculated for survival status with respect to treatment status using Cox proportional hazards models. Both non-adjusted and multivariate-adjusted models were implemented.

*Adjusted for age, sex, year of diagnosis, marital status, race, stage, grade, tumor size, and chemotherapy status.